$RYN

RAYONIER INC

0
0
1

No SEC Form 4 filings for $RYN in the last 30 days.

Med

Rayonier stock price target lowered to $25 by BMO on flat timber outlook

BMO Capital has lowered its price target for Rayonier Inc. (NYSE:RYN) to $25 from $26, maintaining a Market Perform rating due to a flat timber outlook and a lack of near-term catalysts for southern timber pricing recovery. Despite the company trading at a discount to its underlying timberland values and offering a 12.29% dividend yield, the stock is considered overvalued according to InvestingPro analysis. Rayonier also reported mixed Q1 2026 results with a -$0.05 EPS miss but higher-than-expected revenue.

UBS Group AG Increases Holdings in Rayonier Inc. $RYN

UBS Group AG significantly increased its stake in Rayonier Inc. during the fourth quarter, boosting its holdings by 882.5% to 496,024 shares. This comes despite recent insider sales by Rayonier executives and mixed, though improved, financial results that beat earnings estimates but slightly missed revenue projections. Analysts have issued varied ratings for Rayonier, with an average "Hold" rating and an average price target of $24.75.

Impax Asset Management Group plc Cuts Stock Holdings in Rayonier Inc. $RYN

Impax Asset Management Group plc has reduced its stake in Rayonier Inc. (NYSE:RYN) by 5.3% in the fourth quarter, selling 61,905 shares and bringing their total ownership to 1,097,153 shares valued at $23.75 million. Several other institutional investors also adjusted their positions in Rayonier, while corporate insiders, including CFO Wayne Wasechek and Chairman Eric J. Cremers, sold substantial amounts of their shares. Analyst ratings for Rayonier are mixed, with a consensus "Hold" rating and an average price target of $25.50, and the company recently announced a quarterly dividend of $0.26 per share.